TRPV1 and cancer: Understanding the conformational landscape of RTx-dependent TRPV1 gating is not only fundamentally important, but it also has potential therapeutic impact; RTx is currently being evaluated in phase III clinical trials for pain associated with advanced cancer and arthritis of the knee, with positive preliminary results28–30.